Equity Incentive Plan
The Company historically provided stock-based awards through the 2013 Omnibus Incentive Plan, which provided for awards of restricted stock, restricted stock units, stock options, stock appreciation rights and cash awards to directors, directors emeritus, officers, employees and advisory directors. On November 14, 2022, at the Company's annual meeting, stockholders approved the 2022 Omnibus Incentive Plan which provides for the same types of awards as described under the 2013 Omnibus Incentive Plan. Going forward, any future grants will be made under this plan.
The cost of equity-based awards under the 2022 Omnibus Incentive Plan generally is based on the fair value of the awards on their grant date. The maximum number of shares that may be utilized for awards under the plan is 1,000,000. Shares of common stock issued under the plan will be issued out of authorized but unissued shares, some or all of which may be repurchased shares.
The table below presents share-based compensation expense and the estimated related tax benefit for stock options and restricted stock for the dates indicated below:
Year Ended December 31,Six Months Ended December 31, 2023Year Ended June 30, 2023
20252024
Share-based compensation expense$2,173 $1,816 $755 $1,854 
Tax benefit511 427 177 436 
The table below presents stock option activity and related information for the periods indicated below:
OptionsWeighted-
Average
Exercise Price
Remaining Contractual Life (Years)Aggregate Intrinsic Value
Options outstanding at June 30, 2023569,224 $25.69 5.1$141 
Exercised(9,500)15.96 
Forfeited(25,374)26.00 
Options outstanding at December 31, 2023534,350 $25.85 4.6$776 
Exercisable at December 31, 2023459,390 $25.56 4.2$681 
Non-vested at December 31, 202374,960 $27.58 7.4$95 
Options outstanding at December 31, 2023534,350 $25.85 4.6$776 
Exercised(97,113)25.09 
Forfeited(23,600)25.94 
Options outstanding at December 31, 2024413,637 $26.02 3.8$3,169 
Exercisable at December 31, 2024364,667 $25.78 3.4$2,880 
Non-vested at December 31, 202448,970 $27.77 6.7$289 
Options outstanding at December 31, 2024413,637 $26.02 3.8$3,169 
Exercised(57,440)24.97 
Forfeited(1,400)26.72 
Options outstanding at December 31, 2025354,797 $26.19 2.8$5,945 
Exercisable at December 31, 2025329,417 $26.02 2.5$5,575 
Non-vested at December 31, 202525,380 $28.37 5.9$370 
There were no options granted during the years ended December 31, 2025 or 2024 or six months ended December 31, 2023.
At December 31, 2025, the Company had $93 of unrecognized compensation expense related to 25,380 stock options originally scheduled to vest over a five-year period. The weighted average period over which compensation cost related to non-vested awards is expected to be recognized was 0.5 years at December 31, 2025. At December 31, 2024, the Company had $223 of unrecognized compensation expense related to 48,970 stock options originally scheduled to vest over a five-year period. The weighted average period over which compensation cost related to non-vested awards is expected to be recognized was 0.8 years at December 31, 2024. 
The table below presents restricted stock award activity and related information:
Restricted
Stock Awards(1)
Performance-Based Restricted
Stock Units(2)
Weighted-
Average Grant
Date Fair Value
Aggregate
Intrinsic
Value
Non-vested at June 30, 2023108,851 37,330 $27.32 1$3,054 
Granted1,000 6,165 22.91 — 
Vested(1,148)(18,494)23.18 — 
Forfeited(2,560)— 27.53 — 
Non-vested at December 31, 2023106,143 25,001 $27.70 $3,530 
Granted73,502 17,690 26.96 — 
Vested(36,639)(10,683)28.26 — 
Forfeited(4,424)(2,007)27.37 — 
Non-vested at December 31, 2024138,582 30,001 $27.15 $5,678 
Granted60,329 15,444 37.40 — 
Vested(50,326)(9,996)27.24 — 
Forfeited(3,621)(4,108)27.19 — 
Non-vested at December 31, 2025144,964 31,341 $31.52 $7,571 
(1)Restricted stock awards are scheduled to vest over 1.0 year for director awards and 5.0 years for employee awards.
(2)Performance-based restricted stock units are scheduled to vest over 3.0 years assuming the applicable financial goals are met.
At December 31, 2025, unrecognized compensation expense was $3,865 related to 176,305 shares of restricted stock. The weighted average period over which compensation cost related to non-vested awards is expected to be recognized was 1.5 years at December 31, 2025. At December 31, 2024, unrecognized compensation expense was $3,051 related to 168,583 shares of restricted stock. The weighted average period over which compensation cost related to non-vested awards is expected to be recognized was 1.4 years at December 31, 2024.

Historical Timeline

Fiscal YearFiled
2025Mar 13, 2026Showing above
2024Mar 13, 2025
2023Sep 11, 2023
2022Sep 12, 2022
2021Sep 10, 2021
2020Sep 11, 2020
2019Sep 13, 2019
2018Sep 13, 2018
2017Sep 12, 2017
2016Sep 13, 2016

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.